HomeAPGE • NASDAQ
add
Apogee Therapeutics Inc
Previous close
$37.27
Day range
$36.86 - $37.94
Year range
$26.20 - $63.50
Market cap
2.20B USD
Avg Volume
521.02K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 73.16M | 65.82% |
Net income | -66.10M | -95.46% |
Net profit margin | — | — |
Earnings per share | -1.13 | -88.33% |
EBITDA | -72.77M | -65.05% |
Effective tax rate | -0.11% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 505.42M | -25.26% |
Total assets | 657.77M | -17.85% |
Total liabilities | 38.37M | 42.02% |
Total equity | 619.40M | — |
Shares outstanding | 58.57M | — |
Price to book | 3.52 | — |
Return on assets | -26.66% | — |
Return on capital | -27.81% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -66.10M | -95.46% |
Cash from operations | -62.03M | -111.70% |
Cash from investing | 78.12M | 152.54% |
Cash from financing | 1.18M | 886.67% |
Net change in cash | 17.28M | 109.70% |
Free cash flow | -38.71M | -88.09% |
About
Founded
2022
Headquarters
Website
Employees
196
